stockrowTenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
Follow THC
Alert me
Tenet Healthcare Corporation (THC) EPS (diluted)
Tenet Healthcare Corporation's EPS (diluted) for fiscal 2025 was $15.49, down 52.6% from $32.70 in fiscal 2024. Over the twelve months to 30 September 2026 it was $37.19. Over the past ten years it has ranged from −$7.00 (fiscal 2017) to $32.70 (fiscal 2024); the current reading is higher than 91% of that period. Tenet Healthcare Corporation ranks 1st of 48 Medical Care Facilities companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $15.49 | (52.63%) |
| FY2024 | $32.70 | 472.68% |
| FY2023 | $5.71 | 50.66% |
| FY2022 | $3.79 | (54.99%) |
| FY2021 | $8.42 | 124.53% |
| FY2020 | $3.75 | — |
| FY2019 | −$2.24 | — |
| FY2018 | $1.07 | — |
| FY2017 | −$7.00 | — |
| FY2016 | −$1.93 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $15.12 | 53.70% |
| Jun 2026 | $9.84 | 22.85% |
| Mar 2026 | $8.01 | 89.81% |
| Dec 2025 | $4.22 | 9.33% |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| THC Tenet Healthcare Corporation | $37.19 |
| UHS Universal Health Services, Inc. compare | $23.99 |
| CHE Chemed Corporation compare | $20.90 |
| DVA DaVita Inc. compare | $13.58 |
| ENSG The Ensign Group, Inc. compare | $6.72 |
| EHC Encompass Health Corporation compare | $6.40 |
| FMS Fresenius Medical Care AG & Co. KGaA compare | $1.87 |
| PACS PACS Group, Inc. compare | $1.77 |
| CON Concentra Group Holdings Parent, Inc. compare | $1.69 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on THC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement